Neko Health has secured $700 million in Series C funding to expand its AI-powered preventive health screening services into the United States, with an initial clinic planned for New York. The company's approach integrates medical imaging, blood tests, proprietary sensors, and AI analysis with clinician review for comprehensive health assessments. This latest funding round, led by Lightspeed Venture Partners and O.G. Venture Partners, brings Neko Health's total disclosed funding to over $1 billion since 2023, enabling further expansion and research. AI
IMPACT Accelerates the adoption of AI in preventive healthcare, potentially setting new standards for early disease detection and personalized health monitoring.
RANK_REASON Significant funding round for an AI-adjacent health tech company. [lever_c_demoted from significant: ic=1 ai=0.7]
Read on Artificial Intelligence News →
- Alexis Ohanian
- Atomico
- BDT & MSD Partners
- Daniel Ek
- General Catalyst
- Hjalmar Nilsonne
- Lakestar
- Liberty City Ventures
- Lightspeed Venture Partners
- Maria Sharapova
- Mark Zuckerberg
- Neko Health
- New York
- O.G. Venture Partners
- Priscilla Chan
- Thierry Henry
- UK
- United States
- will.i.am
- Zoe Saldaña
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
